JPRN-C000000265已完成2 期
Sequential chemotherapy with FEC(fluoraouracil, epirubicin and cyclophosphamide) and P+H(weekly Paclitaxel+Trastuzumab) as primary systemic therapy for operable breast cancer with HER2 positive disease-a phase 2 study - Sequential chemotherapy with FEC(fluoraouracil, epirubicin and cyclophosphamide) and P+H(weekly Paclitaxel+Trastuzumab) as primary systemic therapy for operable breast cancer with HER2 positive disease-a phase 2 study(PST0402)
Breast Cancer PST Study Group0 个研究点目标入组 42 人开始时间: 2005年10月16日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 42
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 75years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •severe complication suspicious of infection Hypersensitivity for polyoxyethylene castor oil (Cremophor EL) containing drugs grade 3 or 4 peripheral neuropathy Male breast cancer Pregnant or lactating women Doctor' s decision for exclusion
研究者
相似试验
进行中（未招募）
不适用
Sequential first line chemotherapy ECF (epirubicin + cisplatin + 5-fluoruracil) followed by DCF (docetaxel + cisplatin + 5-fluoruracil) in advanced/metastatic gastric cancer HER-2 negative: a phase II study - ECF-DCFpatients with advanced/metastatic gastric cancer not operable HER-2 negativeMedDRA version: 13.1Level: HLTClassification code 10017812Term: Gastric neoplasms malignantSystem Organ Class: 10017947 - Gastrointestinal disordersMedDRA version: 13.1Level: SOCClassification code 10029104Term: Neoplasms benign, malignant and unspecified (incl cysts and polyps)System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 13.1Level: HLGTClassification code 10017991Term: Gastrointestinal neoplasms malignant and unspecifiedSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2010-019756-42-ITAZIENDA OSPEDALIERA SENESE
尚未招募
2 期
eoaduvant chemotherapy woth FOLFOXIRI and anti-EGFR monoclonal antibody for colorectal cancer with liver metastasiscolorectal cancer with liver metastasisJPRN-UMIN000005381Tokushima university20
已完成
不适用
Fluorouracil / Epirubicin / Cyclophosphamide (FEC) followed by Docetaxel plus Cyclophosphamide (TC) as adjuvant chemotherapy for node positive breast cancerBreastCancerJPRN-UMIN000001077Kinki Multidisciplinary Breast Oncology Group35
招募中
2 期
Induction chemotherapy for locally advanced rectal cancer.2023-509758-74-00Catharina Ziekenhuis Stichting128
招募中
1 期
Induction chemotherapy for locally advanced rectal cancer.ocally advanced rectal cancerMedDRA version: 20.0Level: PTClassification code: 10038038Term: Rectal cancer Class: 100000004864CTIS2023-509758-74-00Catharina Ziekenhuis Stichting128